Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (27796)	2/3/1999 4:37:00 PM
From: Cheryl Galt	Respond to of 32384

PS -- because the window was closed: For STARTERS, lets have no i-told-you-so posts regarding the price, whatever it turns out to be in the next few days. Bigger, more crucial issues are pending. Off soapbox. Sorry for rambling. Cheryl

To: Cheryl Galt who wrote (27796)	2/3/1999 5:11:00 PM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

Cheryl, I didn't see the nonsense about a potential problem with Panretin as any sort of joke and I missed the irony, if that was the intent of the poster. It seemed much more akin to misleading posts of the past and it came out of the blue. I certainly intend to point out such absurdities whenever posted on this thread, especially when posted by posters who appear to be incapable of interpreting a press release AFTER it comes out. If you know of any Ligand press releases that indicate that a delay in a drug that had been recommended for approval was due to a potential problem with the drug, I would like to see it.